SEPN1:: Associated with congenital fiber-type disproportion and insulin resistance

被引:117
作者
Clarke, NF
Kidson, W
Quijano-Roy, S
Estournet, B
Ferreiro, A
Guicheney, P
Manson, JI
Kornberg, AJ
Shield, LK
North, KN
机构
[1] Univ Sydney, Childrens Hosp Westmead, Inst Neuromuscular Res, Discipline Paediat & Child Hlth, Sydney, NSW 2006, Australia
[2] Prince Wales Childrens Hosp, Sydney, NSW, Australia
[3] Sydney Childrens Hosp, Sydney, NSW, Australia
[4] Hop Raymond Poincare, AP HP, Garches, France
[5] INSERM, U582, Inst Myol, IFR14, F-75654 Paris 13, France
[6] Univ Paris 06, F-75252 Paris 05, France
[7] Womens & Childrens Hosp, Dept Neurol, Adelaide, SA, Australia
[8] Royal Childrens Hosp, Dept Neurol, Melbourne, Vic, Australia
关键词
D O I
10.1002/ana.20761
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Our first objective was to determine whether SEPN1 gene mutations are a cause of congenital fiber-type disproportion (CFTD), a rare form of congenital myopathy in which relative hypotrophy of type 1 (slow twitch) muscle fibers is the principal abnormality on histology. Second, we investigated an association between SEPN1-related myopathy and insulin resistance. Methods: We sequenced SEPN1 in five unrelated CFTD patients with scoliosis and respiratory muscle weakness and screened an additional 22 CFTD patients for abnormalities in SEPN1 by Western blotting and restriction digest for the 943G -> A mutation. We performed oral glucose tolerance tests (OGTTs) in eight SEPN1-related myopathy patients. Results. Two sisters with CFTD were homozygous for the 943G -> A SEPN1 mutation and had clinical features typical of previously reported patients with SEPN1-related myopathy. Five of eight SEPN1-related myopathy patients had abnormalities on OGTT suggestive of insulin resistance. Interpretation SEPN1 is the second genetic cause of CFTD and the first cause of autosomal recessive CFTD to be identified to our knowledge. CFTD is the fourth clinicopathological presentation that can be associated with mutations in SEPN1. Insulin resistance may be a specific, previously unrecognized aspect of SEPN1-related myopathy.
引用
收藏
页码:546 / 552
页数:7
相关论文
共 16 条
  • [1] THE SPECTRUM OF THE SO-CALLED RIGID SPINE SYNDROME - NOSOLOGICAL CONSIDERATIONS AND REPORT OF 3 FEMALE CASES
    BERTINI, E
    MARINI, R
    SABETTA, G
    PALMIERI, GP
    SPAGNOLI, LG
    VACCARIO, ML
    DEBARSY, T
    [J]. JOURNAL OF NEUROLOGY, 1986, 233 (04) : 248 - 253
  • [2] Two measures of insulin sensitivity provided similar information in a US population
    Bravata, DM
    Wells, CK
    Concato, J
    Kernan, WN
    Brass, LM
    Gulanski, BI
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 2004, 57 (11) : 1214 - 1217
  • [3] Chevenne D, 1999, DIABETES METAB, V25, P459
  • [4] Congenital fiber type disproportion - 30 years on
    Clarke, NF
    North, KN
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2003, 62 (10) : 977 - 989
  • [5] Single section Western blot - Improving the molecular diagnosis of the muscular dystrophies
    Cooper, ST
    Lo, HP
    North, KN
    [J]. NEUROLOGY, 2003, 61 (01) : 93 - 97
  • [6] Desmin-related myopathy with Mallory body-like inclusions is caused by mutations of the selenoprotein N gene
    Ferreiro, A
    Groote, CCD
    Marks, JJ
    Goemans, N
    Schreiber, G
    Hanefeld, F
    Fardeau, M
    Martin, JJ
    Goebel, HH
    Richard, P
    Guicheney, P
    Bönnemann, CG
    [J]. ANNALS OF NEUROLOGY, 2004, 55 (05) : 676 - 686
  • [7] Mutations of the selenoprotein N gene, which is implicated in rigid spine muscular dystrophy, cause the classical phenotype of multiminicore disease:: Reassessing the nosology of early-onset myopathies
    Ferreiro, A
    Quijano-Roy, S
    Pichereau, C
    Moghadaszadeh, B
    Goemans, N
    Bönnemann, C
    Jungbluth, H
    Straub, V
    Villanova, M
    Leroy, JP
    Romero, NB
    Martin, JJ
    Muntoni, F
    Voit, T
    Estournet, B
    Richard, P
    Fardeau, M
    Guicheney, P
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (04) : 739 - 749
  • [8] Ferreiro A, 2000, ANN NEUROL, V48, P745, DOI 10.1002/1531-8249(200011)48:5<745::AID-ANA8>3.0.CO
  • [9] 2-F
  • [10] Gavin JR, 1999, DIABETES CARE, V22, pS5